Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Clinical trial NCT05891795 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05891795
- Sponsor
- Stanford University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2026-01-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.